The Latest Cardiac and Vascular News
SAN JOSE, Calif. and PARIS, Sept. 3, 2019 /PRNewswire/ — Ablative Solutions, Inc., a company pioneering new approaches for the treatment of hypertension, today announced 12-month results from the Peregrine Post-Market Clinical Trial, which were presented today during a symposium at the 2019 European Society of Cardiology (ESC) Congress in Paris. The Peregrine Post-Market Study is […]
LIMERICK, Ireland–(BUSINESS WIRE)–Cook Medical is pleased to announce that Beacon® Tip Catheters are once again available to physicians in Europe. As of September 2019, the catheters are available in the UK, Ireland, Norway, Sweden, Finland, Denmark, Germany, Poland, the Netherlands, Luxembourg, Belgium, France, Switzerland, Austria, Hungary, Spain and Italy. Cook is […]
Renowned medical journal publishes the successful clinical results of remote PCI procedures using CorPath® GRX Robotic System technology WALTHAM, Mass.–(BUSINESS WIRE)–Corindus Vascular Robotics, Inc. (“Corindus” or the “Company”) (NYSE American: CVRS), a leading developer of precision vascular robotics, announced today that EClinicalMedicine, a clinical journal published by the nearly 200-year-old medical journal The Lancet, has […]
DAPA-HF is the first outcomes trial with an SGLT2 inhibitor in patients with heart failure with reduced ejection fraction, with and without type 2 diabetes September 1, 2019 – AstraZeneca today announced detailed results from the landmark Phase III DAPA-HF trial that showed FARXIGA (dapagliflozin) on top of standard […]
10 years ago, RE-LY® marked the first time a randomised trial showed that a non-vitamin K antagonist oral anticoagulant (NOAC) was safer and at least as effective as warfarin for stroke prevention in atrial fibrillation (SPAF)1-3 First major scientific advancement in anticoagulation care in over fifty years Over 100,000 patients have […]
NEW YORK and MELBOURNE, Australia, Aug. 29, 2019 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq: MESO; ASX: MSB) today reported strong operational progress and financial highlights for the fourth quarter and full-year ended June 30, 2019 (FY2019). Mesoblast Chief Executive Dr Silviu Itescu stated: “The Company is well positioned to deliver […]
LOS ANGELES, Aug. 30, 2019 (GLOBE NEWSWIRE) — via NetworkWire — Endonovo Therapeutics Inc. (OTCQB: ENDV) (“Endonovo” or the “Company”), a commercial-stage developer of noninvasive Electroceutical® therapeutic devices, today announces the appointment of orthopedic surgeon Dr. Geoffrey Abrams to its scientific advisory board. “We are thrilled to announce that Dr. Abrams […]
BETHLEHEM, Pa., Aug. 29, 2019 (GLOBE NEWSWIRE) — B. Braun Interventional Systems Inc. (BIS), a company dedicated to providing innovative solutions in the field of congenital and structural interventional cardiology, today announced it has signed an exclusive U.S. distribution agreement with Nano4imaging for their EmeryGlide™ guidewire. The EmeryGlide MR conditional […]
TAMPA, Fla.–(BUSINESS WIRE)–Concept Medical Inc. (CMI) has been granted “Breakthrough Device Designation” from the U.S. Food and Drug Administration (FDA) for MagicTouch AVF, its Sirolimus drug-coated balloon (DCB) catheter, for the treatment of stenotic lesions of Arteriovenous Fistulae or Arteriovenous graft in hemodialysis treatment of renal failure. The FDA received Concept […]
DUBLIN, Aug. 29, 2019 (GLOBE NEWSWIRE) — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the 14th Annual Wells Fargo Securities Healthcare Conference on Thursday, September 5, 2019, in Boston. Mike Coyle, executive vice president and president of the Cardiac and Vascular Group (CVG) […]
